These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 37066775)
1. The Diagnostic and Therapeutic Value of NCAPG as a Proposed Biomarker Candidate in Acute Liver Failure. Zhang L; Ma T; Yan Y; Chen YY; Zhu XH; Ren HZ Comb Chem High Throughput Screen; 2023; 26(15):2738-2748. PubMed ID: 37066775 [TBL] [Abstract][Full Text] [Related]
2. Identification of effective diagnostic biomarker and immune cell infiltration characteristics in acute liver failure by integrating bioinformatics analysis and machine-learning strategies. Yuan M; Yao L; Hu X; Jiang Y; Li L Front Genet; 2022; 13():1004912. PubMed ID: 36246593 [No Abstract] [Full Text] [Related]
3. NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma. Guo ZY; Zhu ZT Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7238-7251. PubMed ID: 34919223 [TBL] [Abstract][Full Text] [Related]
4. Zhang X; Wang H; Han Y; Zhu M; Song Z; Zhan D; Jia J Onco Targets Ther; 2020; 13():11315-11326. PubMed ID: 33177839 [TBL] [Abstract][Full Text] [Related]
5. Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells. Liu K; Li Y; Yu B; Wang F; Mi T; Zhao Y Can J Physiol Pharmacol; 2018 Dec; 96(12):1246-1254. PubMed ID: 30089216 [TBL] [Abstract][Full Text] [Related]
6. NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling. Gong C; Ai J; Fan Y; Gao J; Liu W; Feng Q; Liao W; Wu L Onco Targets Ther; 2019; 12():8537-8552. PubMed ID: 31802891 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway. Yu H; Zou D; Ni N; Zhang S; Zhang Q; Yang L J Ovarian Res; 2022 Aug; 15(1):98. PubMed ID: 35986371 [TBL] [Abstract][Full Text] [Related]
8. Up-regulation of NCAPG mediated by E2F1 facilitates the progression of osteosarcoma through the Wnt/β-catenin signaling pathway. Luo G; Cheng H; Fan J; Sun T Transl Cancer Res; 2024 May; 13(5):2437-2450. PubMed ID: 38881929 [TBL] [Abstract][Full Text] [Related]
9. Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration. Zhang Q; Su R; Shan C; Gao C; Wu P Oncol Res; 2018 Mar; 26(2):269-276. PubMed ID: 29046167 [TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells increase heme oxygenase 1-activated autophagy in treatment of acute liver failure. Wang Y; Wang JL; Ma HC; Tang ZT; Ding HR; Shi XL Biochem Biophys Res Commun; 2019 Jan; 508(3):682-689. PubMed ID: 30528392 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatics and experimental validation were combined to explore lactylation-related biomarkers in HBV-associated acute liver failure. Pei H; Chen YQ; Wu FL; Zhang YY; Zhang X; Li JY; Pan LY; Chen Y; Huang YW J Gastroenterol Hepatol; 2024 Dec; 39(12):2903-2915. PubMed ID: 39285310 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway. Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J Gene; 2021 Jan; 766():145163. PubMed ID: 32980450 [TBL] [Abstract][Full Text] [Related]
13. The regulatory role of microRNA-mRNA co-expression in hepatitis B virus-associated acute liver failure. Pan K; Wang Y; Pan P; Xu G; Mo L; Cao L; Wu C; Shen X Ann Hepatol; 2019; 18(6):883-892. PubMed ID: 31521462 [TBL] [Abstract][Full Text] [Related]
14. The role of NCAPG in various of tumors. Cai X; Gao J; Shi C; Guo WZ; Guo D; Zhang S Biomed Pharmacother; 2022 Nov; 155():113635. PubMed ID: 36095957 [TBL] [Abstract][Full Text] [Related]
15. NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer. Zhou Y; Fan Y; Mao Y; Lou M; Liu X; Yuan K; Tong J Biomark Med; 2022 May; 16(7):523-535. PubMed ID: 35199566 [No Abstract] [Full Text] [Related]
16. Yang H; Pu L; Li R; Zhu R J Gastrointest Oncol; 2023 Apr; 14(2):900-912. PubMed ID: 37201048 [TBL] [Abstract][Full Text] [Related]
17. Identification of key genes and infiltrating immune cells among acetaminophen-induced acute liver failure and HBV-associated acute liver failure. Shi M; Zhou Z; Zhou Z; Shen L; Shen J; Zhou G; Zhu R Ann Transl Med; 2022 Jul; 10(14):775. PubMed ID: 35965803 [TBL] [Abstract][Full Text] [Related]
18. NCAPG deregulation indicates poor patient survival and contributes to colorectal carcinogenesis. Sun DP; Wu CC; Chou CL; Cheng LC; Wang WC; Lin SS; Hung ST; Tian YF; Fang CL; Lin KY Pathol Res Pract; 2023 Jan; 241():154238. PubMed ID: 36442414 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of microRNA-124 prevents the development of acute liver failure through the upregulation of PIM-3. Zan T; Piao L; Yang X; Gu Y; Liu B Exp Physiol; 2020 Jan; 105(1):108-119. PubMed ID: 31628693 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma. Liu W; Liang B; Liu H; Huang Y; Yin X; Zhou F; Yu X; Feng Q; Li E; Zou Z; Wu L Int J Mol Med; 2017 Sep; 40(3):731-738. PubMed ID: 28737823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]